½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > ÆäËû¿¹Ìå > BCL7A¿¹Ô­£¨ÖØ×éµ°°×£©

²úÆ·ÖÐÐÄ

×îвúÆ·

  • BCL7A¿¹Ô­£¨ÖØ×éµ°°×£©

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW16288
    • Ó¦Óà : ½öÏÞÓÚ¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º1mg/100ug
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£º BCL7A¿¹Ô­£¨ÖØ×éµ°°×£©

Ó¢ÎÄÃû³Æ£º BCL7A Antigen (Recombinant Protein)

±ð       Ãû£º B-cell CLL/lymphoma 7A; BCL7

Ïà¹ØÀà±ð£º ¿¹Ô­

´¢       ´æ£º Àä¶³£¨-20¡æ£©

¸ÅÊö

Fusion protein corresponding to N terminal 187 amino acids of human BCL7A

¼¼Êõ¹æ¸ñ

Full name:

B-cell CLL/lymphoma 7A

Synonyms:

BCL7

Swissprot:

Q4VC05

Gene Accession:

BC113627

Purity:

>85%, as determined by Coomassie blue stained SDS-PAGE

Expression system:

Escherichia coli

Tags:

His tag C-Terminus, GST tag N-Terminus

Background:

This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.

  • ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
  • ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿